Develops extracellular vesicle, synthetic lipid nanoparticle and hybrid gene-delivery systems as non-viral, targeted personalized therapies for genetic disorders. Sublicenses delivery vehicles to pharmaceutical companies and research labs for development of gene-based therapeutics.